Table 1. Pooled analyses of the association between NLRP1 polymorphisms and susceptibility to vitiligo.
SNP | Models | M | I2 | Pheterogeneity | Stratification | case/control (N) | OR [95% CI] | Passociation |
---|---|---|---|---|---|---|---|---|
rs12150220 | T vs. A | Fixed | 33.5% | 0.222 | overall/ Asian | 563/1,351 (3) | 1.17 [1.00~1.38] | 0.057 |
TT vs. AA | Fixed | 0.0% | 0.470 | overall/ Asian | 563/1,351 (3) | 1.55 [0.77~1.72] | 0.492 | |
AT vs. AA | Fixed | 0.0% | 0.896 | overall/ Asian | 563/1,351 (3) | 1.32 [1.07~1.64] | 0.011 | |
AT+TT vs. AA | Fixed | 0.0% | 0.861 | overall/ Asian | 563/1,351 (3) | 1.29 [1.05~1.59] | 0.014 | |
TT vs. AA+AT | Fixed | 40.3% | 0.187 | overall/ Asian | 563/1,351 (3) | 0.97 [0.66~1.42] | 0.866 | |
carrier T vs. A | Fixed | 0.0% | 0.513 | overall/ Asian | 563/1,351 (3) | 1.15 [0.95~1.38] | 0.149 | |
rs2670660 | G vs. A | Random | 84.6% | < 0.001 | overall | 719/1,534 (5) | 1.26 [0.84~1.90] | 0.258 |
88.2% | < 0.001 | Asian | 653/1,441(4) | 1.19 [0.72~1.96] | 0.491 | |||
88.2% | < 0.001 | PHWE > 0.05 | 693/1,473 (4) | 1.20 [0.75~1.90] | 0.452 | |||
GG vs. AA | Random | 81.7% | < 0.001 | overall | 719/1,534 (5) | 1.62 [0.73~3.59] | 0.234 | |
85.9% | < 0.001 | Asian | 653/1,441(4) | 1.40 [0.53~3.73] | 0.500 | |||
86.2% | < 0.001 | PHWE > 0.05 | 693/1,473 (4) | 1.47 [0.58~3.71] | 0.414 | |||
AG vs. AA | Random | 76.3% | 0.002 | overall | 719/1,534 (5) | 1.49 [0.88~2.53] | 0.142 | |
78.6% | 0.003 | Asian | 653/1,441 (4) | 1.30 [0.73~2.32] | 0.368 | |||
80.7% | 0.001 | PHWE > 0.05 | 693/1,473 (4) | 1.37 [0.77~2.43] | 0.289 | |||
AG+GG vs. AA | Random | 84.2% | < 0.001 | overall | 719/1,534 (5) | 1.53 [0.84~2.81] | 0.165 | |
86.9% | < 0.001 | Asian | 653/1,441 (4) | 1.35 [0.68~2.66] | 0.395 | |||
87.6% | < 0.001 | PHWE > 0.05 | 693/1,473 (4) | 1.40 [0.72~2.74] | 0.327 | |||
GG vs. AA+AG | Random | 64.4% | 0.024 | overall | 719/1,534 (5) | 1.25 [0.77~2.01] | 0.370 | |
72.9% | 0.011 | Asian | 653/1,441(4) | 1.20 [0.64~2.24] | 0.573 | |||
73.2% | 0.011 | PHWE > 0.05 | 693/1,473 (4) | 1.21 [0.68~2.13] | 0.513 | |||
carrier G vs. A | Random | 56.5% | 0.056 | overall | 719/1,534 (5) | 1.18 [0.89~1.56] | 0.262 | |
66.9% | 0.028 | Asian | 653/1,441(4) | 1.13 [0.80~1.61] | 0.481 | |||
66.8% | 0.029 | PHWE > 0.05 | 693/1,473 (4) | 1.14 [0.83~1.58] | 0.420 | |||
rs6502867 | C vs. T | Random | 80.5% | < 0.001 | overall | 719/1,534 (5) | 1.06 [0.70~1.61] | 0.768 |
64.7% | 0.037 | Asian | 653/1,441(4) | 1.29 [0.93~1.80] | 0.130 | |||
85.1% | < 0.001 | PHWE > 0.05 | 693/1,473 (4) | 1.05 [0.65~1.70] | 0.831 | |||
CC vs. TT | Random | 65.3% | 0.021 | overall | 719/1,534 (5) | 1.30 [0.62~2.72] | 0.490 | |
52.1% | 0.099 | Asian | 653/1,441(4) | 1.73 [0.92~3.26] | 0.397 | |||
71.0% | 0.016 | PHWE > 0.05 | 693/1,473 (4) | 1.40 [0.64~3.07] | 0.397 | |||
TC vs. TT | Random | 73.6% | 0.004 | overall | 719/1,534 (5) | 1.04 [0.64~1.69] | 0.873 | |
55.7% | 0.080 | Asian | 653/1,441(4) | 1.27 [0.85~1.90] | 0.238 | |||
79.9% | 0.002 | PHWE > 0.05 | 693/1,473 (4) | 0.96 [0.55~1.69] | 0.901 | |||
TC+CC vs. TT | Random | 80.1% | < 0.001 | overall | 719/1,534 (5) | 1.07 [0.63~1.81] | 0.805 | |
65.7% | 0.033 | Asian | 653/1,441(4) | 1.34 [0.87~2.07] | 0.186 | |||
85.1% | < 0.001 | PHWE > 0.05 | 693/1,473 (4) | 1.01 [0.55~1.87] | 0.963 | |||
CC vs. TT+TC | Fixed | 37.7% | 0.170 | overall | 719/1,534 (5) | 1.59 [1.21~2.09] | 0.001 | |
15.1% | 0.316 | Asian | 653/1,441(4) | 1.69 [1.27~2.24] | < 0.001 | |||
41.1% | 0.165 | PHWE > 0.05 | 693/1,473 (4) | 1.63 [1.24~2.16] | 0.001 | |||
carrier C vs. T | Random | 54.7% | 0.065 | overall | 719/1,534 (5) | 1.07 [0.79~1.46] | 0.653 | |
10.8% | 0.339 | Asian | 653/1,441(4) | 1.26 [1.04~1.53] | 0.021 | |||
65.9% | 0.032 | PHWE > 0.05 | 693/1,473 (4) | 1.05 [0.79~1.46] | 0.782 |
SNP, Single Nucleotide Polymorphism; HWE, Hardy-Weinberg equilibrium; Pheterogeneity, P value of Cochrane's Q statistic for the assessment of heterogeneity; M, statistical model; OR, odds ratio; CI, confidence interval; Passociation, P value of association test;
N, Number of included case-control studies.